je.st
news
Arena: Belviq Scripts See Modest Rise, Revenue Story Not Promising
2015-03-21 10:01:41| Biotech - Topix.net
While many Arena investors would like to see a pretty picture painted about the sales of Belviq, the fact of the matter is that script sales are not hitting the type of growth that is needed to drive the equity. In addition, with a price cut, the revenue story is not what is needed either.
Tags: story
rise
revenue
scripts
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||
|
|||